Key result
Syndromic ACHD carries high multimorbidity with ~46% aortopathy, alongside marked heart failure undertreatment.
Why the study?
Syndromes associated with congenital heart defects have diverse genetic bases, and understanding their molecular and clinical characteristics is essential for improving management of syndromic ACHD patients.
Cross-Sectional (n=107)
Yes
Alerts clinicians to multimorbidity and therapy gaps in syndromic ACHD; leaves open whether closing these gaps improves prognosis.
Numerous syndromes affecting patients have phenotypes that include congenital heart defects (CHDs). These disorders have fascinated physicians for many years, raising questions about how seemingly disparate aspects of human development can be perturbed together in striking, but consistent, ways. Paralleling the major advances in human genetics during recent decades, we have come to understand that some of these syndromes arise from gross defects in chromosomal number, some from subtler alterations in genomic regions, and still others from point mutations in specific genes. These disorders, largely mendelian in nature, have provided researchers with the wherewithal to discover disease genes underlying CHD. Although some of these medical conditions are relatively rare, their solution has often provided insights that could be applied toward understanding the basis of nonsyndromic CHD. In this review, recent progress toward uncovering the molecular basis of several forms of syndromic CHD is discussed.
No takes yet. Share an insight, caveat, or question.
Bruce D. Gelb (2001) conducted a cross-sectional in Adult congenital heart disease (ACHD) with genetic syndromes and heart failure risk (n=107). Genetic syndromes and disorders was evaluated on Clinical phenotype, cardiac and extracardiac comorbidities, and contemporary management patterns. Among 107 adults with congenital heart disease and genetic syndromes, patients exhibited a high burden of multimorbidity, including intrinsic aortopathy (45.8%), alongside marked underutilization of guideline-directed heart failure therapies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: